Go to content
UR Home

Zelltherapie am Augenhintergrund – gestern, heute, morgen

Brandl, Caroline (2017) Zelltherapie am Augenhintergrund – gestern, heute, morgen. medizinische genetik 29 (2), pp. 208-216.

Full text not available from this repository.

at publisher (via DOI)

Other URL: http://doi.org/10.1007/s11825-017-0140-8


The endpoint of most retinal degenerative disorders is a loss of cells in the retinal pigment epithelium and/or the neurosensory retina, leading to irreversible visual impairment. Therefore, therapeutic strategies in the late disease stages also need to address the replacement of lost cells or tissues. In recent years, rapid advances have been made in the field of stem cell-based cellular ...


Export bibliographical data

Item type:Article
Institutions:Medicine > Lehrstuhl für Augenheilkunde
Medicine > Lehrstuhl für Humangenetik
Medicine > Institut für Epidemiologie und Präventivmedizin > Lehrstuhl für Genetische Epidemiologie
Identification Number:
Keywords:PLURIPOTENT STEM-CELLS; RETINAL-PIGMENT EPITHELIUM; AGE-RELATED MACULOPATHY; MACULAR DEGENERATION; OPHTHALMOLOGY TREATMENT; CLINICAL-TRIAL; DYSTROPHIES; RPE; SYSTEM; SCOTS; Retinal dystrophy; Age-related macular degeneration; Induced pluripotent stem cells; Retinal pigment epithelium; Haplobank
Dewey Decimal Classification:600 Technology > 610 Medical sciences Medicine
Refereed:Yes, this version has been refereed
Created at the University of Regensburg:Yes
Item ID:38911
Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons